EC Healthcare Announced Strategic Alliance with Prudential EC Healthcare Feb 13, 2023 19:09 HKT/SGT Read More
노보텍 글로벌 보고서: 아시아 태평양 지역에서 1단계 임상시험의 확고한 성장 Novotech Health Holdings Pte Ltd Feb 13, 2023 06:00 HKT/SGT Read More
First Patient in the US Dosed in a Global Multicentre Phase 3 Clinical Study of Bevacizumab for treatment of Ophthalmic Diseases Essex Bio-Technology Limited Feb 10, 2023 21:06 HKT/SGT Read More
亿胜生物宣布贝伐珠单抗眼科适应症国际多中心III期临床研究完成美国首例患者给药 Essex Bio-Technology Limited Feb 10, 2023 20:39 HKT/SGT Read More
億勝生物宣佈貝伐珠單抗眼科適應症國際多中心III期臨床研究完成美國首例患者給藥 Essex Bio-Technology Limited Feb 10, 2023 20:38 HKT/SGT Read More
Novotech Global Report: Robust Phase 1 Trial Growth Across Asia Pacific Novotech Health Holdings Pte Ltd Feb 10, 2023 19:00 HKT/SGT Read More
亚太地区细胞与基因研究:Novotech 的增长速度比世界其它地区快 50% Novotech Health Holdings Pte Ltd Feb 04, 2023 07:00 HKT/SGT Read More
아시아 태평양 지역 세포유전자 연구: 노보텍이 세계의 나머지 모든 기관들보다 50% 더 빠르게 성장 Novotech Health Holdings Pte Ltd Feb 04, 2023 07:00 HKT/SGT Read More
亞太地區細胞與基因研究:Novotech 的增長速度比世界其它地區快 50% Novotech Health Holdings Pte Ltd Feb 04, 2023 07:00 HKT/SGT Read More
Asia Pacific Cell & Gene Research Growing 50% Faster than ROW Novotech Health Holdings Pte Ltd Feb 03, 2023 13:00 HKT/SGT Read More
Ocumension Therapeutics Announces The Completion Of The Phase I Clinical Trial Of Its Class I New Drug For The Treatment Of Dry Eye -- OT-202 Ocumension Therapeutics Feb 03, 2023 10:01 HKT/SGT Read More